Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New expanded indication of Enbrel approved by FDA

June 7, 2000

CD40 agonist MAbs reduce disease severity in a mouse model of rheumatoid arthritis

June 7, 2000

DHFR inhibitors and their use in rheumatic conditions

June 6, 2000

Potent, broad-spectrum and orally active MMP inhibitor under evaluation at Ono

June 6, 2000

Aventis presents new inhibitors of IL-1beta production and their use

June 5, 2000

Novel class of inhibitors of cysteine proteases of the ICE/ced-3 family designed by Idun

June 2, 2000

Genelabs begins NDA submission of GL-701 for treatment of lupus

June 1, 2000

Phase III results for Orthovisc disappointing

June 1, 2000

Rofecoxib associated with reduced risk of GI adverse effects

May 31, 2000

Inhibitors of COX-2 with an imidazole structure revealed by Uriach

May 30, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...